Clinical Trials Directory

Trials / Unknown

UnknownNCT00806689

Full Disclosure Observational Cardiac Rhythm Documentation Follow-up After Surgical Atrial Fibrillation Therapy

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University of Luebeck · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

24 hour Holter monitoring (24HM) is commonly used to assess cardiac rhythm after surgical therapy of atrial fibrillation. This "snapshot" rhythm documentation leaves a large diagnostic window of non recorded atrial arrhythmias and as such a large amount of uncertainty in follow-up result assessment. To improve accuracy of rhythm surveillance thus gaining a more "real-life" scenario of post surgical ablation therapy cardiac rhythm a new insertable cardiac rhythm monitor device (Reveal® XT 9525, Medtronic Inc., Minneapolis, MN, USA) with full observational continuous heart rhythm documentation is implanted. In order to verify different follow-up strategies after surgical atrial fibrillation therapy, a comparison of different follow-up scenarios (symptoms, different cardiac documentation devices i.e. ECG and 24 hour Holter monitor, at different follow-up time points) is performed intraindividually. Thus the reliability of these devices and follow-up strategies to define success after ablation therapy is evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDURECardiac rhythm monitor implantationpost surgical procedure implantation of insertable event recorder for long time heart rhythm surveillance afte ablation therapy
DEVICEReveal® XT 9525During cardiac surgery after stand alone or concomitant ablation procedure, an insertable loop recorder will be implanted subcutaneously in left pectoral region. After surgery, patients will be monitored regularly in a quarterly basis by performing telemetry of the device in the outpatient clinic. Furthermore, home telemetry will be performed once a month for optimal heart rhythm observation.

Timeline

Start date
2007-07-01
Primary completion
2008-12-01
Completion
2011-07-01
First posted
2008-12-11
Last updated
2010-07-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00806689. Inclusion in this directory is not an endorsement.